Pakistan’s customs authorities have revised the import valuation of glass tubing and glass containers used by the pharmaceutical industry, issuing a fresh ruling aimed at aligning duty assessments with current international prices.

The Directorate General of Customs Valuation in Karachi announced the update through Valuation Ruling No. 2067 of 2026, covering imports of pharmaceutical glass products sourced mainly from China and European countries.

The new ruling replaces an earlier valuation framework that was withdrawn following appeals filed by industry stakeholders. Importers had argued that previously notified customs values did not reflect prevailing global market rates, prompting authorities to initiate a fresh review.

During consultations, importers informed customs officials that the import price of clear glass containers from China had declined compared to earlier benchmarks. They also pointed out pricing differences between printed and non-printed variants, although officials noted that limited trade data was available for printed products.

Customs authorities said all representations, supporting documents, and market information submitted by stakeholders were examined before finalizing the revised values. Officials conducted a market inquiry but found that these products are specialized industrial inputs not readily available in Pakistan’s local market, making direct price comparison difficult.

Authorities further assessed alternative valuation methods but concluded they could not be applied due to insufficient reliable information on manufacturing costs and value addition in exporting countries.

According to customs officials, the updated valuation is intended to bring import prices closer to actual transaction values, address concerns raised by importers, and ensure more accurate assessment of customs duties on pharmaceutical packaging materials.